Important Dates
Early Bird Registration :6th July 2026
Paper Submission Deadline :11th July 2026
Last Date of Registration : 21st July 2026
Date of Conference : 5th - 6th August 2026
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Track 01
Advancements in Genetic Biomarkers
This track will explore the latest discoveries in genetic biomarkers and their implications for disease diagnosis and treatment. Emphasis will be placed on innovative approaches to biomarker identification and validation.
Track 02
Molecular Diagnostics: Techniques and Applications
This session will focus on cutting-edge molecular diagnostic techniques and their applications in clinical settings. Participants will discuss the integration of these techniques into routine diagnostics and their impact on patient outcomes.
Track 03
Genomic Assays in Clinical Genomics
This track will cover the development and application of genomic assays in clinical genomics. Discussions will include the challenges and opportunities presented by these assays in the context of personalized medicine.
Track 04
Biomarker Discovery and Validation
This session will address the methodologies and technologies used in biomarker discovery and validation. Emphasis will be placed on the importance of robust validation processes to ensure clinical applicability.
Track 05
Predictive and Prognostic Markers in Disease Management
This track will examine the role of predictive and prognostic markers in the management of various diseases. Participants will discuss how these markers can inform treatment decisions and improve patient outcomes.
Track 06
High-Throughput Screening in Biomarker Research
This session will highlight the use of high-throughput screening technologies in the identification of novel biomarkers. The focus will be on innovative applications and the potential for accelerating biomarker discovery.
Track 07
Liquid Biopsy: A Paradigm Shift in Diagnostics
This track will explore the emerging field of liquid biopsy and its implications for non-invasive diagnostics. Discussions will include the technical challenges and clinical applications of liquid biopsy in various diseases.
Track 08
Mutation Detection Techniques in Genomics
This session will focus on the latest techniques for mutation detection in genomic studies. Participants will discuss the significance of these techniques in understanding disease mechanisms and treatment responses.
Track 09
Gene Panels and Their Clinical Utility
This track will examine the development and application of gene panels in clinical practice. Emphasis will be placed on their role in personalized medicine and the challenges associated with their implementation.
Track 10
Protein Biomarkers: Discovery and Applications
This session will focus on the discovery and application of protein biomarkers in disease diagnosis and monitoring. Participants will discuss the technological advancements that facilitate protein biomarker research.
Track 11
Therapeutic Biomarkers and Targeted Therapies
This track will explore the role of therapeutic biomarkers in the development of targeted therapies. Discussions will include the implications of these biomarkers for treatment efficacy and patient stratification.